Yellow Fever Vaccine Recommendations for Travelers and Lab Workers, 2002

200,000 estimated annual cases of clinical yellow fever disease are reported in the description. This report from the Advisory Committee on Immunization Practices (ACIP) updates CDC recommendations for yellow fever vaccine use, summarizing epidemiology, immunogenicity, and safety data. It was authored by J. Erin Staples of the National Center for Emerging and Zoonotic Infectious Diseases.

Use Cases

• Informing travel health advisories based on described risk factors like destination, season, and activities
• Developing vaccine administration protocols based on described contraindications and precautions
• Modeling disease burden and mortality based on described epidemiology in sub-Saharan Africa and tropical South America

Strengths

• Provides specific epidemiological estimates, including 200,000 annual cases and 30,000 deaths
• Offers concrete recommendations for persons aged 9 months and older traveling to endemic areas
• Cites a specific source report (MMWR 2002;51[No. RR-17])

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download
• Last update date is unknown; freshness unverified
• Row count is unknown, which may limit suitability assessment

Provenance

Source

Advisory Committee on Immunization Practices (ACIP) / Centers for Disease Control and Prevention (CDC)

Collection Method

Report summarizing committee recommendations and available information.

Time Range

Recommendations published in 2002, summarizing information available up to that point.

Geography

Focus on areas with yellow fever virus transmission, specifically sub-Saharan Africa and tropical South America.